DE69527350D1 - Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten - Google Patents

Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten

Info

Publication number
DE69527350D1
DE69527350D1 DE69527350T DE69527350T DE69527350D1 DE 69527350 D1 DE69527350 D1 DE 69527350D1 DE 69527350 T DE69527350 T DE 69527350T DE 69527350 T DE69527350 T DE 69527350T DE 69527350 D1 DE69527350 D1 DE 69527350D1
Authority
DE
Germany
Prior art keywords
periodontal
pyridinolin
implants
crosslinking
indication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527350T
Other languages
English (en)
Other versions
DE69527350T2 (de
Inventor
V Giannobile
E Lynch
Ray C Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Institute of Molecular Biology Inc
Original Assignee
Harvard College
Institute of Molecular Biology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Institute of Molecular Biology Inc filed Critical Harvard College
Publication of DE69527350D1 publication Critical patent/DE69527350D1/de
Application granted granted Critical
Publication of DE69527350T2 publication Critical patent/DE69527350T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/146666Bile pigment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/147777Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
DE69527350T 1994-02-16 1995-01-13 Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten Expired - Lifetime DE69527350T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/197,131 US5516699A (en) 1994-02-16 1994-02-16 Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity
PCT/US1995/000509 WO1995022763A1 (en) 1994-02-16 1995-01-13 Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity

Publications (2)

Publication Number Publication Date
DE69527350D1 true DE69527350D1 (de) 2002-08-14
DE69527350T2 DE69527350T2 (de) 2003-03-13

Family

ID=22728172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527350T Expired - Lifetime DE69527350T2 (de) 1994-02-16 1995-01-13 Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten

Country Status (13)

Country Link
US (1) US5516699A (de)
EP (1) EP0745221B1 (de)
JP (1) JP3521913B2 (de)
KR (1) KR970701349A (de)
CN (1) CN1145116A (de)
AT (1) ATE220458T1 (de)
AU (1) AU1726495A (de)
CA (1) CA2183452C (de)
DE (1) DE69527350T2 (de)
DK (1) DK0745221T3 (de)
ES (1) ES2179867T3 (de)
PT (1) PT745221E (de)
WO (1) WO1995022763A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
AU2015332556B2 (en) 2014-10-14 2021-04-29 Samuel Lynch Compositions for treating wounds
EP3477306A1 (de) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Klassifizierung von parodontitispatienten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735945A (en) * 1986-03-13 1988-04-05 Vipont Laboratories, Inc. Method for inhibiting bone resorption and collagenase release
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase

Also Published As

Publication number Publication date
JPH09509486A (ja) 1997-09-22
ES2179867T3 (es) 2003-02-01
CA2183452A1 (en) 1995-08-24
CA2183452C (en) 2007-03-27
DK0745221T3 (da) 2002-11-04
ATE220458T1 (de) 2002-07-15
CN1145116A (zh) 1997-03-12
AU1726495A (en) 1995-09-04
KR970701349A (ko) 1997-03-17
PT745221E (pt) 2002-11-29
EP0745221B1 (de) 2002-07-10
DE69527350T2 (de) 2003-03-13
JP3521913B2 (ja) 2004-04-26
WO1995022763A1 (en) 1995-08-24
EP0745221A1 (de) 1996-12-04
EP0745221A4 (de) 1998-06-10
US5516699A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE60025526D1 (de) Elisa für vegf
TR200002023T2 (tr) Bilgisayarlı ortodontik teşhis ve alet sağlama cihazı.
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
FR2801106B1 (fr) Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
DK0931264T3 (da) Fremgangsmåde til diagnosticering af aterosklerose
DK0931265T3 (da) Diagnistisk metode for aterosklerose
Carr et al. The relationship of Periotest values, biomaterial, and torque to failure in adult baboons.
DE69527350T2 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
FI933291A0 (fi) Foerfarande foer paovisning av anti-rna-antikroppar
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE397413T1 (de) System zur messung von parameter identifizierten patienten
Fartash et al. Markers of inflammation in crevicular fluid from peri‐implant rnucosa surrounding single crystal sapphire implants
WO1992005278A3 (en) Method for the determination of the differential expression of mrna for the amyloid precursor protein (app)
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
FI951778A0 (fi) Menetelmä allergian toteamiseksi
RU93039981A (ru) Способ оценки выраженности воспалительного процесса в тканях пародонта
RU95106406A (ru) Способ оценки состояния тканей пародонта
DK1008854T3 (da) Kalibrator baseret på en samling af plasma fra mere end 200 patienter
Mokeem Peri-implant crevicular fluid volume in dental implant recall patients at king saud university
RU98113331A (ru) Способ диагностики бактериальной аллергии
Efstratios Papazoglou E unctional stability of the dentition is a prerequi-site to normal mastication, and periodic mea
UA37731A (uk) Спосіб діагностики розсіяного склерозу

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803